葡萄糖调节蛋白78对胃癌SGC7901细胞转移的影响及机制
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:探讨钙离子螯合剂BAPTA-AM和钙离子载体A23187对胃癌SGC7901细胞GRP78表达水平的影响,分析GRP78表达改变对胃癌细胞侵袭转移能力的影响,并初步探讨其可能的机制。
     方法:体外培养人胃癌SGC7901细胞株,并将其分为BAPTA-AM处理组、对照组和A23187处理组,采用RT-PCR和Western-blot检测各组细胞GRP78在mRNA和蛋白水平的表达,经体外侵袭实验和伤口愈合实验检测各组细胞侵袭和转移能力的变化,运用免疫细胞化学、Western-blot检测各组细胞E-钙粘蛋白和N-钙粘蛋白的表达,分析GRP78在胃癌细胞转移中的作用机制。
     结果:
     1. A23187组、对照组、20μmol/LBAPTA-AM组、40μmol/LBAPTA -AM组以及60μmol/LBAPTA-AM组GRP78-mRNA与内参β-actin的灰度值之比分别为:1.070±0.005、1.011±0.012、0.701±0.009、0.543±0.009以及0.348±0.013,GRP78-mRNA在A23187组的表达量较对照组升高(P<0.01),在3个BAPTA-AM组的表达量较对照组降低(P<0.01);A23187组、对照组及40μmol/LBAPTA-AM组GRP78蛋白与内参β-actin的灰度值之比分别为:0.911±0.004、0.823±0.007、0.647±0.015,GRP78蛋白在A23187组的表达量较对照组升高(P<0.01),在BAPTA-AM组的表达量较对照组降低(P <0.01)。
     2. A23187组48小时划痕愈合程度较对照组升高(79.68%±0.91% vs 57.32%±0.80%,P<0.01),每视野细胞平均数较对照组增加(89±2 vs 59±2,P<0.01);BAPTA-AM组48小时划痕愈合程度较对照组降低(39.92%±0.79% vs 57.32%±0.80%,P<0.01),每视野细胞平均数较对照组减少(43±1 vs 59±2,P<0.01)。A23187组侵袭转移能力较对照组增强,BAPTA-AM组侵袭转移能力较对照组减弱。
     3.免疫细胞化学、Western blot实验结果显示,A23187组E-钙粘蛋白的表达水平较对照组降低(0.106±0.003 vs 0.122±0.003,P<0.01; 0.495±0.010 vs 0.709±0.008,P<0.01),BAPTA-AM组E-钙粘蛋白的表达水平较对照组升高(0.133±0.003 vs 0.122±0.003,P<0.01;0.915±0.017 vs 0.709±0.008,P<0.01);A23187组N-钙粘蛋白的表达水平较对照组升高(0.143±0.003 vs 0.131±0.003,P<0.01;0.541±0.009 vs 0.344±0.006,P<0.01 ), BAPTA-AM组N-钙粘蛋白的表达水平较对照组降低(0.104±0.004 vs 0.131±0.003,P<0.01;0.210±0.004 vs 0.344±0.006,P<0.01)。
     结论:BAPTA-AM可下调胃癌细胞SGC7901中GRP78的表达,而A23187则可诱导其表达。GRP78的表达水平可影响胃癌细胞的侵袭和转移能力,其机制可能与GRP78改变了E-钙粘蛋白和N-钙粘蛋白的表达从而影响了肿瘤的上皮间叶转化水平有关。
Objective: To study the effect of BAPTA-AM and A23187 on GRP78 expression of gastric carcinoma SGC-7901 cells in vitro, examine the role of GRP78 in invasion and metastasis of these tumor cells, and investigate their mechanism initially.
     Methods: The SGC7901 cells were cultured in medium in vitro and divided into three groups: BAPTA-AM-treated group, control group and A23187-treated group. RT-PCR and Western blot were used to assess the expression of GRP78 at both mRNA and protein levels. The invasion and metastasis levels of SGC7901 cells were evaluated by matrigel invasion assay and a scratch wound assay. Immuno-cytochemistry and Western blot were performed to test the expression of E-cadherin and N-cadherin.
     Results:
     1. The ratios of gray values in A23187 group, control group, 20μmol/LBAPTA-AM group, 40μmol/LBAPTA-AM group, 60μmol/LBA -PTA-AM group were as follow: 1.070±0.005,1.011±0.012,0.701±0.009, 0.543±0.009,0.348±0.013, the expression of GRP78-mRNA was elevated in A23187 group and reduced in BAPTA-AM groups compared with that in control group(P<0.01); The ratios of GRP78 protein gray values andβ-actin gray values in A23187 group, control group, 40μmol/L BAPTA- -AM group were as follow: 0.911±0.004、0.823±0.007、0.647±0.015, the expression of GRP78 protein was elevated in A23187 group and reduced in BAPTA-AM groups compared with that in control group(P<0.01).
     2. In A23187 group, the degree of healing was higher than that in control group(79.68%±0.91% vs 57.32%±0.80%,P<0.01) and the mean value of the invasive cells in one filed was more than that in control group(89±2 vs 59±2,P<0.01). In BAPTA-AM group, the degree of healing was lower than that in control group (39.92%±0.79% vs 57.32%±0.80%, P<0.01)and the mean value of the invasive cells in one filed was less than that in control group(43±1 vs 59±2,P<0.01). The invasion and migration levels were increased in A23187 group and decreased in BAPTA-AM group compared with that in control group.
     3. Immuno-cytochemistry, Western blot showed the expression level of E-cadherin protein was decreased in A23187 group(0.106±0.003 vs 0.122±0.003,P<0.01; 0.495±0.010 vs 0.709±0.008,P<0.01)and increased in BAPTA-AM group compared with that in control group(0.133±0.003 vs 0.122±0.003,P<0.01; 0.915±0.017 vs 0.709±0.008,P<0.01); The expression level of N-cadherin protein was elevated in A23187 group(0.143±0.003 vs 0.131±0.003,P<0.01;0.541±0.009 vs 0.344±0.006,P<0.01)and reduced in BAPTA-AM group compared with that in control group(0.104±0.004 vs 0.131±0.003,P<0.01;0.210±0.004 vs 0.344±0.006,P<0.01).
     Conclusion: BAPTA-AM was an inhibitor of GRP78 expression in gastric carcinoma SGC7901 cells, and A23187 could induce expression of GRP78. Moreover, the regulation of GRP78 could affect the invasion and metastasis levels of tumor cells in vitro and it may be resulted from the change of N-cadherin expression and E-cadherin expression, which play an important role in EMT.
引文
[1]刘荣华,王世宣,马湘一,等. GRP78在三种不同乳腺癌细胞中的表达及意义[J].中国肿瘤临床,2008,35(9):520-522.
    [2]刘荣华,王世宣,马湘一,等.葡萄糖调节蛋白78在乳腺癌细胞侵袭及转移中的作用[J].广东医学,2008,29(10):1617-1619.
    [3] Su R, Li Z, Li H, et al.Grp78 promotes the invasion of hepatocellular carcinoma[J].BMC Cancer,2010(19):10-20.
    [4] Zhuang L, Scolyer RA, Lee CS,et al. Expression of glucose-regulated stress proteinGRP78 is related to progression of melanoma[J]. Histopathology, 2009, 54(4): 462-4-70.
    [5] Papalas JA, Vollmer RT, Gonzalez-Gronow M, et al. Patterns of GRP78 and MTJ1expression in primary cutaneous malignant melanoma[J]. Mod Pathol, 2010, 23(1):13-4-143.
    [6]苏荣健,李贞,程留芳.特异性下调葡萄糖调节蛋白78表达对肝细胞癌侵袭和转移能力的影响[J].细胞生物学杂志,2007,(29): 889-894.
    [7] Katanasaka Y, Ishii T, Asai T, et al. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78[J]. Int J Cancer, 2010, 127(11): 2685-2698.
    [8] Dong D, Ni M, Li J,et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development[J]. Cancer Res,2008,68(2):498-505.
    [9] Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-kappa B, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associatedGRP78[J]. J Biol Chem,2006,281(19):13694-707.
    [10]Dai RY, Chen SK, Yan DM, et al. PI3K/Akt promotes GRP78 accumulation and inhibits endoplasmic reticulum stress-induced apoptosis in HEK293 cells[J]. Folia Biol (Praha),2010,56(2):37-46.
    [11]Kishi S, Shimoke K, Nakatani Y, et al. Nerve growth factor attenuates2-deoxy-d-glucose-triggered endoplasmic reticulum stress-mediated apoptosis via enhanced expression of GRP78[J]. Neurosci Res,2010,66(1): 14-21.
    [12]Wang Y, Wang W, Wang S, et al. Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells[J]. BMC Cancer,2008,(8):372.
    [13]Jiang L, Zhang L, Wang Q, et al. Down-regulation of GRP78 Enhances Chemotherapy Sensitivity to VP-16 in Lung Adenocarcinoma[J]. Zhongguo Fei Ai Za Zhi,2009,12(11):1159-63.
    [14]Shiu RP, Pastan IH. Properties and purification of a glucose-regulat-edprotein from chick embryo fibroblasts[J]. Biochim Bopphys Acta,1979,576(1):141-150.
    [15]Zhang J, Jiang YX, J ZL, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer[J]. Clin Exp Metastasis,2006,23:401-410.
    [16]Gosky D, Chatterjee S. Down-regulation of topoisomerase II is caused by up-regulation of GRP78[J]. Biochem Biophys Res Commun, 2003,300: 327-332.
    [17]Rao RV, Peel A, Logvinova A, del Rio G, Hermel E, Yokota T, Goldsmith PC,Ellerby LM, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78[J]. FEBS Lett,2002,514:122–128.
    [18]Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties[J]. J Biol Chem,1985,(260): 3440–3450.
    [19]Ye Y, Xiao Y, Wang W, etal. ERalpha signaling through slug regulates E-cadherin and EMT[J]. Oncogene,2010,29(10):1451-62.
    [20]Cavallaro U,Schafhauser B,Christofori G.Cadhefins and the tumour progression:is it all in a swilch?[J].Cancer Lett,2002,176(2):123-128.
    [1] Kiang JG, Tsokos GC. Heat shock protein 70 kD: molecular biology Biochemistry, and physiology[J]. Pharmacol Ther,1998,80(2):183-201.
    [2] Caspersen C, Pedersen PS, Treiman M. The sarco/endoplasmic reticulum calcium-ATPase 2βis an endoplasmic reticulum stress-inducible protein[J]. Biol Chem,2000,275(29):22363-22372.
    [3] Chen YY, Chen G, Fan Z, et al. GSK3beta and endoplasmic reticulum stressmediate rotenone-induced death of SK-N-MC neuroblastoma cells[J]. Biochem Pharmacol,2008,76: 128–138.
    [4] Wang Y, Wang W, Wang S, et al.Down-regulation of GRP78 is associated with the sensitivity of chemotherapy to VP-16 in small cell lung cancer NCI-H446 cells[J]. BMC Cancer,2008,8:372.
    [5] Sasaya H, Utsumi T, Shimoke K, et al. Nicotine Suppresses Tunicamycin-induced, But Not Thapsigargin-Induced, Expression of GRP78 during ER Stress-Mediated Apoptosis in PC12 Cells[J]. Bio chem,2008,144: 251–257.
    [6] Peter Baumeister, Dong DZ, Fu Y, et al. Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor–induced apoptosis[J]. Mol Cancer Ther,2009,8(5): 1086-94.
    [7] Zhao P, Ueda JY, Kozone I, et al. New glycosylated derivatives of versipelostatin, the GRP78/Bip molecular chaperone down-regulator, from Streptomyces versipellis 4083-SVS6[J]. Org Biomol Chem,2009,7(7):1454-60.
    [8] Ni M, Lee AS. ER chaperones in mammalian development and human Diseases[J]. FEBS Lett,2007,581(19):3641-51.
    [9] Rauschert N, Br?ndlein S, Holzinger E,et al. A new tumor-specific variant of GRP78 as target for antibody-based therapy[J]. Lab Invest,2008,88:375-386.
    [10]Gonzalez-Gronow M, Cuchacovich M, Llanos C, et al. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucoseregulated protein 78 isolated from patient serum[J]. Cancer Res,2006,66:11424-11431.
    [11]Bhattacharjee G, Ahamed J, Pedersen B, et al. Regulation of tissue factor-mediated initiation of the coagulation cascade by cell surface grp78[J]. Arterioscler Thromb Vasc Biol,2005,25:1737-1743.
    [12]Jindadamrongwech S, Thepparit C, and Smith DR. Identifications of GRP78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2[J]. Arch Virol,2004,149:915-927.
    [13]Triantafilou K, Fradelizi D, Wilson K,et al. GRP78, a co-receptor for Coxsackie virus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization[J]. J Virol,2002,76: 633-643.
    [14]Gonzalez-Gronow M, Kaczowka SJ, Payne S, et al. Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel[J]. J Biol Chem,2007,282: 32811-32820.
    [15] Shani G, Fischer WH, Justice NJ, et al. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth[J]. Mol Cell Biol,2008,28(2):666-677.
    [16]Su R, Li Z, Li H, et al.Grp78 promotes the invasion of hepatocellular carcinoma[J]. BMC Cancer,2010,(19):10-20.
    [17]苏荣健,李贞,程留芳.特异性下调葡萄糖调节蛋白78表达对肝细胞癌侵袭和转移能力的影响[J].细胞生物学杂志,2007,(29):889-894.
    [18]Zhang J, Jiang YX, J ZL, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer[J]. Clin Exp Metastasis,2006,23:401-410.
    [19]Zhuang L, Scolyer RA, Lee CS,et al. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma[J]. Histopathology, 2009,54(4):462-470.
    [20]Papalas JA, Vollmer RT, Gonzalez-Gronow M, et al. Patterns of GRP78 and MTJ1 expression in primary cutaneous malignant melanoma[J]. Mod Pathol, 2010,23(1):134-143.
    [21]刘荣华,王世宣,马湘一,等. GRP78在三种不同乳腺癌细胞中的表达及意义[J].中国肿瘤临床,2008,35(9):520-522.
    [22]Cavallaro U, Schafhauser B,Christofori G. Cadhefins and the tumour progression:is it all in a swilch?[J].Cancer Lett,2002,176(2):123-128.
    [23]Katanasaka Y, Ishii T, Asai T, et al. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78[J]. Int J Cancer,2010,127(11):2685-2698.
    [24]Dong D, Ni M, Li J,et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development[J]. Cancer Res,2008,68(2):498-505.
    [25]Hauck CR, Hsia DA, Llic D, et al. v-Src SH3-enhanced interaction with focaladhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion[J].J Biol Chem,2002,277 (15):12487-12490.
    [26]Dasari VR, Kaur K, Velpula KK,et al. Down regulation of Focal Adhesion Kinase (FAK) by cord blood stem cells inhibits angiogenesis in glioblastoma [J]. Aging (Albany NY),2010,2(11):791-803.
    [27]Han EK, Mcgonigal T, Wang J, et al. Functional analysis of Focal Adhesion Kinase (FAK) reduction by small inhibitory RNAs[J]. Anticancer Res,2004, 24(6):3899-3905.
    [28]Qiau Y,Corum L,Meug Q, et al. PI3K induced actin filament remode1ing through Akt and p70S6K1: implication of essential role in cell migration[J]. Am J Physiol Cell Physiol,2004,286(9):C153-C163.
    [29]Ye Y, Xiao Y, Wang W,etal. ER alpha signaling through slug regulates E-cadherin and EMT[J]. Oncogene,2010,29(10):1451-62.
    [30]Zhang D,Brodt P.Type l insulin-llke growth factor regu lates MTl-MMP synthesis and tumor invasion via PI3–kinase/Akt signaling[J]. Oncogene, 2003,22(7):974-982.
    [31]Hm MM, Hemmin BA. Inhibition of protein kinase B/Akt. Implications for cancer therapy [J]. Pharmacol Ther,2002,93:243.
    [32]Kim D, Kim S, Koh H, et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production [J]. FASEB J,2001, 15(11): 1953-1962.
    [33]Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-kappa B, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associatedGRP78[J].J BiolChem,2006,281(19):13694-707.
    [34]Dai RY, Chen SK, Yan DM, et al. PI3K/Akt promotes GRP78 accumulation and inhibits endoplasmic reticulum stress-induced apoptosis in HEK293 cells[J]. Folia Biol (Praha),2010,56(2):37-46.
    [35]Kishi S, Shimoke K, Nakatani Y, et al. Nerve growth factor attenuates 2-deoxyd-glucose-triggered endoplasmic reticulum stress-mediated apoptosis via enhanced expression of GRP78[J]. Neurosci Res,2010,66(1): 14-21.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700